NGF
Beta-nerve growth factor
Also known as: NGF_HUMAN, NGFB
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P01138
- Gene
- NGF
- Ensembl
- ENSG00000134259
- Chromosome
- 1
- Canonical length
- 241 aa
- Protein class
- Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins
- Secretome location
- Secreted in other tissues
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene is a member of the NGF-beta family and encodes a secreted protein which homodimerizes and is incorporated into a larger complex. This protein has nerve growth stimulating activity and the complex is involved in the regulation of growth and the differentiation of sympathetic and certain sensory neurons. Mutations in this gene have been associated with hereditary sensory and autonomic neuropathy, type 5 (HSAN5), and dysregulation of this gene's expression is associated with allergic rhinitis. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
241 residues, UniProt reviewed canonical sequence.
>P01138|NGF
1 MSMLFYTLIT AFLIGIQAEP HSESNVPAGH TIPQAHWTKL QHSLDTALRR ARSAPAAAIA
61 ARVAGQTRNI TVDPRLFKKR RLRSPRVLFS TQPPREAADT QDLDFEVGGA APFNRTHRSK
121 RSSSHPIFHR GEFSVCDSVS VWVGDKTTAT DIKGKEVMVL GEVNINNSVF KQYFFETKCR
181 DPNPVDSGCR GIDSKHWNSY CTTTHTFVKA LTMDGKQAAW RFIRIDTACV CVLSRKAVRR
241 ALocalizationUniProt · AlphaFold · HPA
Whether an antibody against NGF can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 22 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 22 nTPM
- ovary: 19 nTPM
- blood vessel: 18 nTPM
- adipose tissue: 14 nTPM
- fallopian tube: 13 nTPM
- endometrium: 9.4 nTPM
Single-cell type
- hepatic stellate cells: 129 nCPM
- pericytes: 125 nCPM
- leydig cells: 112 nCPM
- vascular smooth muscle cells: 91 nCPM
- mesothelial cells: 76 nCPM
- adipocytes: 65 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hypothalamus: 2.6 nTPM
- choroid plexus: 2.3 nTPM
- pons: 2 nTPM
- thalamus: 1.9 nTPM
- cerebral cortex: 1.8 nTPM
- medulla oblongata: 1.6 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NGF.
Disease | AllUniProt
Conditions NGF is implicated in, by any mechanism.
- Neuropathy, hereditary sensory and autonomic, 5 (HSAN5) MIM:608654
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 194 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Disease | AutoantibodyPubMed
Conditions in which antibodies against NGF are reported. Each links to that disease's full target list.
ReferencesPubMed · IEDB
Publications for NGF from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
17 publications
- Natural autoantibodies against the nerve growth factor in autoimmune diseases.
1993 · J Neuroimmunol · RCR 1.3 · 39 citations - Cyclosporin A as an Alternative Neuroimmune Strategy to Control Neurites and Recover Neuronal Tissues in Leprosy.
2022 · Neuroimmunomodulation · RCR 1.2 · 9 citations - Serum anti-S100b, anti-GFAP and anti-NGF autoantibodies of IgG class in healthy persons and patients with mental and neurological disorders.
2000 · Autoimmunity · RCR 0.9 · 36 citations - Nerve growth factor (NGF) autoantibodies and NGF in the synovial fluid: implications in spondylarthropathies.
1996 · Autoimmunity · RCR 0.8 · 26 citations - Analysis of cerebrospinal fluid of Alzheimer patients. Biomarkers and toxic properties.
2008 · Pharmacology · RCR 0.6 · 22 citations
Show 12 more
- Evidence that natural autoantibodies against the nerve growth factor (NGF) may be potential carriers of NGF.
1997 · J Neuroimmunol · RCR 0.5 · 19 citations - Peripheral neutralization of nerve growth factor induces immunosympathectomy and central neurodegeneration in transgenic mice.
2010 · J Alzheimers Dis · RCR 0.5 · 18 citations - Low frequency of plasma nerve-growth factor detection is associated with death of memory B lymphocytes in HIV-1 infection.
2003 · Clin Exp Immunol · RCR 0.5 · 26 citations - Naturally occurring antibodies against nerve growth factor in human and rabbit sera: comparison between control and herpes simplex virus-infected patients.
1991 · J Neuroimmunol · RCR 0.4 · 13 citations - Anti-NGF autoantibodies and NGF in sera of Alzheimer patients and in normal subjects in relation to age.
1997 · Autoimmunity · RCR 0.2 · 6 citations - [A comparison of some indices of innate and adaptive immunity in different types of schizophrenia].
2003 · Zh Nevrol Psikhiatr Im S S Korsakova · RCR 0.2 · 5 citations - Circulating NGF antibody alters the distribution of NG2 and CD56 positive cells in the brain of an animal model of inflammatory disorder.
2003 · Arch Ital Biol · RCR 0.1 · 6 citations - Autoantibodies to nerve growth factor in disorders of mental development in infants.
2001 · Neurosci Behav Physiol · RCR 0.1 · 5 citations - [Immune status in children with psychomotor development disturbances].
2003 · Zh Nevrol Psikhiatr Im S S Korsakova · RCR 0.1 · 2 citations - [Autoimmune mechanisms in the genesis of developmental abnormalities of the nervous system].
2001 · Vestn Ross Akad Med Nauk · RCR 0 · 1 citations - [Clinical, immunological, and electrophysiological matching in Raynaud's syndrome].
2005 · Klin Med (Mosk) - [Influence of high concentration of antibodies to NGF during early embryogenesis on formation of mice behavior in postnatal period].
2012 · Patol Fiziol Eksp Ter
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.53
- gnomAD pLI
- 0.82
- gnomAD missense Z
- 0.9
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- axon extension
- cell surface receptor protein tyrosine kinase signaling pathway
- circadian rhythm
- extrinsic apoptotic signaling pathway in absence of ligand
- extrinsic apoptotic signaling pathway via death domain receptors
- modulation of chemical synaptic transmission
- negative regulation of cell population proliferation
- negative regulation of neuron apoptotic process
- nerve development
- nerve growth factor signaling pathway
- neuron apoptotic process
- neuron projection morphogenesis
- neurotrophin TRK receptor signaling pathway
- peripheral nervous system development
- positive regulation of axon extension
- positive regulation of collateral sprouting
- positive regulation of ERK1 and ERK2 cascade
- positive regulation of gene expression
- positive regulation of neuron differentiation
- positive regulation of neuron maturation
- positive regulation of neuron projection development
- positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- positive regulation of protein ubiquitination
- positive regulation of Ras protein signal transduction
- regulation of neurotransmitter secretion
- regulation of release of sequestered calcium ion into cytosol
- sensory perception of pain
Molecular functions
- growth factor activity
- lipid binding
- metalloendopeptidase inhibitor activity
- nerve growth factor receptor binding
- transmembrane receptor protein tyrosine kinase activator activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Nerve growth factor-related
- Nerve growth factor conserved site
- Nerve growth factor-like
- Cystine-knot cytokine
- Nerve growth factor family
- Nerve growth factor, beta subunit
- Nerve growth factor, beta subunit, mammalian
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NGF in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NGF as an antibody target. Whether an autoantibody or antibody against NGF could matter depends on whether native NGF is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NGF is annotated as secreted, so native NGF circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label NGF as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...